C07C275/60

Aminocarbonylcarbamate compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: ##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: ##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

AMINOCARBONYLCARBAMATE COMPOUNDS

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound:

##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

AMINOCARBONYLCARBAMATE COMPOUNDS

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound:

##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: ##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: ##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate Compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound:

##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate Compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound:

##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: ##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.

Aminocarbonylcarbamate compounds

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: ##STR00001## wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R.sub.1 and R.sub.2 are independently H or alkyl; R.sub.3 is H, alkyl or aralkyl; and R.sub.4 is H or aryl.